Abstract
Psychopharmacologic interventions are commonly used in oncology and palliative care settings. However, there have been relatively few rigorously designed and conducted psychopharmacologic studies in these patient populations. Given a growing recognition of the importance of identifying and treating varied forms of distress in cancer patients and survivors, there is an urgent need to develop a more robust evidence base to guide psychopharmacologic treatment decisions. Such an evidence base would help address stigma regarding psychopharmacologic treatments as well as help clinicians working in psycho-oncology to educate their oncology colleagues. In addition to reviewing the rationale for psychopharmacologic research in psycho-oncology, this chapter describes a number of areas that are ripe for psychopharmacologic research in psycho-oncology, for example: efficacy and tolerability of antipsychotics for mood, anxiety, or insomnia; antipsychotic use in delirium; and psychostimulant use for fatigue and cognitive effects of cancer treatments. This chapter also reviews limitations of existing research on psychopharmacologic treatments in psycho-oncology. Suggestions for future research are provided, in the interest of providing “real-world” effectiveness data for the management of the numerous common symptoms and syndromes that occur in cancer patients and survivors. Examples include the study of co-occurring symptoms (e.g., depression and fatigue), research on the treatment of so-called subsyndromal levels of depressive or anxiety symptoms, and studies of specific treatments in specific cancer populations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012;30(11):1206–14.
Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, Olden M, Pessin H, Lichtenthal W, Sjoberg D, Cassileth BR. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol. 2012;30(12):1304–9.
Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073–8.
Candy B, Jackson KC, Jones L, Tookman A, King M. Drug therapy for symptoms associated with anxiety in adult palliative care patients. Cochrane Database Syst Rev. 2012;10, CD004596.
Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012;30(11):1160–77.
Chochinov HM. Depression in cancer patients. Lancet Oncol. 2001;2(8):499–505.
Dunn LB, Cooper BA, Neuhaus J, West C, Paul S, Aouizerat B, Abrams G, Edrington J, Hamolsky D, Miaskowski C. Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychol. 2011;30(6):683–92.
Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol. 2012;30(11):1178–86.
Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, Steel JL, Cuijpers P, Mohr DC, Berendsen M, Spring B, Stanton AL. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012;104(13):990–1004.
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol. 2012;30(12):1335–42.
Holland JC. History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med. 2002;64(2):206–21.
Holland JC, Andersen B, Breitbart WS, Dabrowski M, Dudley MM, Fleishman S, Foley GV, Fulcher C, Greenberg DB, Greiner CB, Handzo RG, Jacobsen PB, Knight SJ, Learson K, Levy MH, Manne S, McAllister-Black R, Peterman A, Riba MB, Slatkin NE, Valentine A, Zevon MA, NCCN. Distress management. J Natl Compr Canc Netw. 2007;5(1):66–98.
Institute of Medicine. Cancer care for the whole patient: meeting psychosocial health needs. Washington, DC: The National Academies Press; 2007.
Irwin KE, Greer JA, Khatib J, Temel JS, Pirl WF. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival. Chron Respir Dis. 2013;10(1):35–47.
Jacobsen PB, Ransom S. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw. 2007;5(1):99–103.
Jacobsen PB, Donovan KA, Swaine ZN, et al. Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. In: Chang AE, Ganz PA, Hayes DF, et al., editors. Oncology: an evidence-based approach. New York: Springer; 2006. p. 1552–79.
Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol. 2012;30(11):1151–3.
Krystal JH, Sanacora G, Duman RS. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry. 2013;73(12):1133–41.
Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry. 2013;13:140.
Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012;30(11):1187–96.
Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
Northouse L, Williams AL, Given B, McCorkle R. Psychosocial care for family caregivers of patients with cancer. J Clin Oncol. 2012;30(11):1227–34.
Phelps AC, Lauderdale KE, Alcorn S, Dillinger J, Balboni MT, Van Wert M, Vanderweele TJ, Balboni TA. Addressing spirituality within the care of patients at the end of life: perspectives of patients with advanced cancer, oncologists, and oncology nurses. J Clin Oncol. 2012;30(20):2538–44.
Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, Perez-Cruz P, Heist RS, Temel JS. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30(12):1310–5.
Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011;25(1):36–51.
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.
Sheinfeld Gorin S, Krebs P, Badr H, Janke EA, Jim HS, Spring B, Mohr DC, Berendsen MA, Jacobsen PB. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol. 2012;30(5):539–47.
Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006;23(1):35–40.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.
Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol. 2012;30(11):1197–205.
Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;414(32):80–92.
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28.
Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Key References
-
Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012b;30(11):1206–14.
-
Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, Steel JL, Cuijpers P, Mohr DC, Berendsen M, Spring B, Stanton AL. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012b;104(13):990–1004.
-
Krystal JH, Sanacora G, Duman RS. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry. 2013b;73(12):1133–41.
-
Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012b;30(11):1187–96.
-
Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011b;25(1):36–51.
-
Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol. 2012b;30(11):1197–205.
Suggested Further Reading
-
Billings JA, Block SD. Integrating psychiatry and palliative medicine: the challenges and opportunities. In: Chochinov HM, Breitbart WS, editors. Handbook of psychiatry in palliative medicine. 2nd ed. New York: Oxford; 2009. p. 13–21.
-
Holland JC, Weiss TR. History of psycho-oncology. In: Holland JH, Breitbart W, editors. Psycho-oncology. 2nd ed. New York: Oxford; 2010. p. 3–14.
-
Jacobsen PB. Translating psychosocial oncology research to clinical practice. In: Holland JH, Breitbart W, editors. Psycho-oncology. 2nd ed. New York: Oxford; 2010. p. 642–7.
-
Johansen C, Grassi L. International psycho-oncology: present and future. In: Holland JH, Breitbart W, editors. Psycho-oncology. 2nd ed. New York: Oxford; 2010. p. 655–62.
-
Rosenstein DL, Miller FG. Research ethics in psycho-oncology. In: Holland JH, Breitbart W, editors. Psycho-oncology. 2nd ed. New York: Oxford; 2010. p. 630–5.
-
Stefanek M. Basic and translational psycho-oncology research. In: Holland JH, Breitbart W, editors. Psycho-oncology. 2nd ed. New York: Oxford; 2010. p. 637–41.
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Alici, Y., Dunn, L.B. (2014). Research Issues in Psychopharmacology in Oncology and Palliative Care Settings. In: Grassi, L., Riba, M. (eds) Psychopharmacology in Oncology and Palliative Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40134-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-40134-3_21
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40133-6
Online ISBN: 978-3-642-40134-3
eBook Packages: MedicineMedicine (R0)